hairy cell leukaemia
hairy cell leukemia
hairy-cell leukaemia
hairy-cell leukemia

Occupational exposures, animal exposure and smoking as risk factors for hairy cell leukaemia evaluated in a case-control study.

Arachnia propionica pneumonia in hairy cell leukaemia.

Hairy cell leukaemia is now regarded as a variant of chronic lymphocytic leukaemia and has been grouped with it.

Hagberg H, Lundholm L: Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia.

A team of Italian scientists used massively parallel sequencing to pinpoint mutation V600E as a likely driver mutation in 100% of cases of hairy cell leukaemia.

These include leukaemic reticuloendotheliosis (hairy cell leukaemia), Gaucher's disease, HIV-induced encephalopathy, osteoclastoma and osteoporosis, and metabolic bone diseases.

Else M, Dearden CE, Matutes E, et al.: Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.

Men are four to five times more likely to develop hairy cell leukemia than women.

Different types of treatment are available for patients with hairy cell leukemia.

Groups are used in place of stages for hairy cell leukemia.

The exact cause of hairy cell leukemia is not known.

These and other symptoms may be caused by hairy cell leukemia.

Gender and age may affect the risk of developing hairy cell leukemia.

There is no standard staging system for hairy cell leukemia.

About 6,000 people in the United States have hairy cell leukemia.

As with many cancers, the cause of hairy cell leukemia is unknown.

But when it was tested in patients with hairy cell leukemia the results were spectacular, he said.

There are less common leukemias, such as hairy cell leukemia.

Hairy cell leukemia is a cancer of the blood and bone marrow.

Today, hairy cell leukemia has a high remission rate.

It was first approved, in 1986, for treating hairy cell leukemia, an extremely rare blood cancer.

Pentostatin is used to treat a specific type of blood cancer (hairy cell leukemia).

In hairy cell leukemia, too many blood stem cells develop into lymphocytes.

If this test is negative, the diagnosis of hairy cell leukemia is unlikely.

Refractory hairy cell leukemia has not responded to treatment.

The doctors thought I had everything from anemia to lymphoma to hairy cell leukemia.

Patients with hairy cell leukemia who are symptom-free typically do not receive immediate treatment.

Possible signs of hairy cell leukemia include tiredness, infections, and pain below the ribs.

Whether the hairy cell leukemia responds to treatment.

In untreated hairy cell leukemia, some or all of the following conditions occur:

The best clinical success has been achieved in treating patients with refractory hairy cell leukemia.

Hairy cell leukemia is a very rare cancer that causes the body to make too many white blood cells (lymphocytes).

Matutes E, Wotherspoon A, Catovsky D: The variant form of hairy-cell leukaemia.

But even there, he said, the commercial potential is limited: there are only about 6,000 cases of hairy-cell leukemia each year.

They include a wide range of products, from human growth hormone to vaccines, quick pregnancy tests to a life-saving treatment for hairy-cell leukemia.

It was ineffective against the more common cancers and was found to be effective mainly against hairy-cell leukemia. '

John Moore first visited UCLA Medical Center on October 5, 1976, after learning he had hairy-cell leukemia.

Diagnostic confusion with acute myelocytic leukemia (AML), hairy-cell leukemia, and malignant lymphoma is not uncommon.

It turned out that he had hairy-cell leukemia, a rare cancer that filled his spleen with malignant blood cells until it bulged like an overfilled inner tube.

Hoffman MA, Janson D, Rose E, et al.: Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up.

Mr. Walton had long struggled against two types of cancer, hairy-cell leukemia, which weakens the immune system by attacking white blood cells, and a bone-marrow cancer called multiple myeloma.

Piro LD, Carrera CJ, Carson DA, et al.: Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.

The F.D.A. gave Hoffmann-LaRoche of Nutley approval to market a biological entity to fight hairy-cell leukemia, a powder drug that helps doctors diagnose bronchial problems and a capsule for psoriasis treatment.

Scripps, which employs 190 principal investigators, 390 postdoctoral researchers and 500 technicians, counts among its major accomplishments in the past few years the discovery of a treatment for hairy-cell leukemia and the purification of Factor 8, which is used in the treatment of hemophilia.

Since then, Johnson & Johnson has poured in at least $125 million, and Dr. Lerner said only one marketable product had been developed: this month the company got approval from the Food and Drug Administration for a drug to treat a form of cancer, hairy-cell leukemia.